企业 | 技术平台 | 技术应用 | 主要合作伙伴 |
IsisPharma | antisensetechnology | 以RNA为靶点的反义药物 | BiogenIdec, Genzyme, GlaxoSmithKline, AstraZeneca, Roche |
SeattleGenetics | ADCtechnology | 抗体偶联药物 | Genentech,Pfizer, Abbvie, Bayer, GlaxoSmithKline, Takeda, DaiichiSankyo |
ImmunoGen | TAPtechnology | 抗体偶联药物 | Genentech,Bayer, Amgen, |
BindTherapeutics | Accurins | 靶向载药纳米粒 | Amgen,Pfizer, AstraZeneca |
Ambrx | proteinmedicinal chemistry | 蛋白质精确修饰,抗体偶联药物 | Bristol-MyersSquibb, Merck, Astellas |
SantarisPharma | LNA drugplatform | 以RNA为靶点的锁核酸药物 | Bristol-MyersSquibb, Pfizer, GlaxoSmithKline, Shire |
Immunocore | ImmTACtechnology | 单克隆TCR | Genentech,GlaxoSmithKline |
ArrayBioPharma | Arraydiscovery platform | 小分子药物发现及前期开发 | AstraZeneca,Genentech, Novartis |
AstexPharma | fragment-baseddrug discovery | 基于碎片发现小分子药物 | Novartis,Janssen, AstraZeneca, GlaxoSmithKline |
Ablynx | Nanobodytechnology | 单域迷你抗体 | AbbVie,Boehringer Ingelheim, Merck Serono, Merck, Novartis |
InovioPharma | syntheticDNA vaccines | 合成的DNA疫苗 | Roche, VGXInternational, NIH/NIAID |
MolecularPartners | DARPinplatform | 人工设计锚蛋白 | Janssen,Allergan, Centocor, Roche |
EvotecAG | drugdiscovery solutions | 靶点确证与药物发现 | Bayer,Boehringer Ingelheim, Genentech, Janssen, AstraZeneca |
EnsembleTherapeutics | DNA-programmedchemistry | 大环肽类药物 | Novartis,Bristol-Myers Squibb, Genentech, Boehringer Ingelheim,Alexion |
CoNCERTPharma | DCEPlatform | 氘代药物 | GlaxoSmithKline,Celgene, Avanir Pharma, Jazz Pharma |
Genmab | DuoBodytechnology | 双靶点抗体 | Novartis,Janssen, Kyowa Hakko Kirin |
Adimab | Yeast-basedscreening system | 全人源抗体高速筛选优化 | GlaxoSmithKline,Lilly, Merck, Novartis, Pfizer, Roche, Celgene, Biogen Idec,Gilead |
AlnylamPharma | RNAiplatform | RNAi药物 | Takeda,Genzyme, Novartis, Biogen Idec, GlaxoSmithKline,AstraZeneca |
Depomed | Acuformdelivery technology | 缓控释制剂 | Janssen,Covidien, Boehringer Ingelheim, Merck |
FormaTherapeutics | industrializeddiscovery engine | 小分子抗癌药物的发现 | Celgene,Janssen, Boehringer Ingelheim, Genentech, EISAI Pharma,Novartis |
XenonPharma | ExtremeGenetics discovery platform | 基于临床遗传学的药物发现 | Merck,Genentech, Teva |
BioInvent | n-CoDeRantibody library | 抗体筛选 | Bayer,Daiichi Sankyo, Mitsubishi Tanabe, Servier |
HalozymeTherapeutics | ENHANZEtechnology | 生物制品皮下注射给药技术 | Roche,Baxter Healthcare, Pfizer, ViroPharma |
注:AstexPharma已于今年9月被OtsukaPharma收购。
联系客服